| dc.description.abstract |
Khayelitsha, South Africa, with high burdens of rifampicin-resistant tuberculosis (RR-TB) and HIV co-infection. The objective of this study was to describe time to antiretroviral treatment (ART) initiation among HIV-infected RR-TB patients initiating RR-TB treatment and to assess the association between time to ART initiation and treatment outcomes. A retrospective cohort study of patients with RR-TB and HIV co-infection not on ART at RRTB treatment initiation. Despite wide variation in time to ART initiation among RR-TB patients, no differences in mortality or treatment success were observed. However, a significant proportion of patients did not initiate ART despite receiving >4 months of RR-TB treatment. Programmatic priorities should focus on ensuring all patients with RR-TB/HIV co-infection initiate ART regardless of CD4 count, with special attention for patients with CD4 counts 100 to initiate ART as soon as possible after RR-TB treatment initiation. |
en |
| dc.bibliographictitle |
Daniels, J.F., Khogali, M., Mohr, E., Cox, V., Moyo, S., Edginton, M., Hinderaker, S.G., Meintjes, G., Hughes, J., De Azevedo, V., Van Cutsem, G. & Cox, H.S. (2015) Time to ART initiation among patients treated for Rafampicin-resistant tuberculosis in Khayelitsha, South Africa: impact on mortality and treatment success. PLoS One. 10(11):Online. http://hdl.handle.net/20.500.11910/21862 http://hdl.handle.net/20.500.11910/21862 |
en |